Status:
COMPLETED
Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer
Lead Sponsor:
University of Arkansas
Conditions:
Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if a brief writing intervention works to improve quality of life outcomes in adult patients newly diagnosed with advanced stage cancer.
Detailed Description
A diagnosis of cancer may challenge one's former assumptions and beliefs about themselves and the world and potentially compromise quality of life (QoL). The primary aim of the study is to explore the...
Eligibility Criteria
Inclusion
- within 8 weeks of being informed of diagnosis (primary or recurrent)
- cancer stage III or IV of a primary solid tumor, or a high-grade hematological malignancy, and
- age 18 years or older
Exclusion
- medical condition precluding participation (e.g., too ill or fatigued, acute mental confusion as determined by the treating physician), or
- enrolled in other psychosocial experiments
Key Trial Info
Start Date :
May 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2023
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT05235750
Start Date
May 27 2022
End Date
July 7 2023
Last Update
March 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205
2
Arkansas Hospice
North Little Rock, Arkansas, United States, 72116